Login / Signup

An update on the global treatment of invasive fungal infections.

Melissa E MunzenAriana D Goncalves GarciaLuis R Martinez
Published in: Future microbiology (2023)
Fungal infections are a serious problem affecting many people worldwide, creating critical economic and medical consequences. Fungi are ubiquitous and can cause invasive diseases in individuals mostly living in developing countries or with weakened immune systems, and antifungal drugs currently available have important limitations in tolerability and efficacy. In an effort to counteract the high morbidity and mortality rates associated with invasive fungal infections, various approaches are being utilized to discover and develop new antifungal agents. This review discusses the challenges posed by fungal infections, outlines different methods for developing antifungal drugs and reports on the status of drugs currently in clinical trials, which offer hope for combating this serious global problem.
Keyphrases
  • candida albicans
  • clinical trial
  • healthcare
  • cell wall
  • randomized controlled trial
  • emergency department
  • adverse drug
  • combination therapy
  • phase ii
  • phase iii
  • smoking cessation